SARS-CoV-2 T-cell response in COVID-19 convalescent patients with and without lung SEQUELAE
ERJ open research
; 2022.
Article
in English
| EuropePMC | ID: covidwho-1688440
ABSTRACT
Patients infected by SARS-CoV-2 may develop pneumonia (COVID19) and require hospital admission and, eventually, critical care [1]. This has been related with a weaker innate immune response with impaired production of type I interferons [2]. In this setting, an antigen specific T-cell response is needed for the elimination of SARS-CoV-2, as well as to develop long-lasting memory to respond to potential future SARS-CoV-2 infections [3, 4]. However, this response needs to be contained once the virus is eradicated to avoid further damaging the host.
Search on Google
Collection:
Databases of international organizations
Database:
EuropePMC
Topics:
Long Covid
Language:
English
Journal:
ERJ open research
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS